---
title: "Improved metabolomic biomarker discovery in admixed American cohorts using genetics-driven scores"
id: "medrxiv-1-enhanced-power-and-transferability-for-genetics-driven-metabolomic-biomarker"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-enhanced-power-and-transferability-for-genetics-driven-metabolomic-biomarker"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1?rss=1"
published_at: "2026-09-07T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Improved metabolomic biomarker discovery in admixed American cohorts using genetics-driven scores
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-enhanced-power-and-transferability-for-genetics-driven-metabolomic-biomarker
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1?rss=1)
- **Published At:** 2026-09-07T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study assessed transferability and performance of **genetic scores** for metabolomic traits developed in a European cohort (INTERVAL) when applied to admixed American (AMR) populations. - Researchers evaluated 141 genetic scores in the Mexico City Prospective Study (MCPS; n=132,336), finding a median predictive R2 of 0.027 for INTERVAL-trained models in MCPS. - Training Bayesian ridge prediction models within MCPS markedly improved performance, achieving a median R2 of 0.083 on a withheld 20% MCPS subset. - MCPS-trained models also outperformed INTERVAL-trained models among UK Biobank participants of AMR ancestry (n=600), with median R2 0.070 versus 0.046. - Applying MCPS-trained models to All of Us AMR participants produced five times as many significant metabolome-wide associations (FDR-corrected P<0.05) across three cardiometabolic diseases: **ischaemic heart disease**, **type 2 diabetes**, and **chronic kidney disease**, compared with INTERVAL-trained models. - The authors emphasize that metabolomics is underrepresented in non-European ancestries despite high metabolic disease burden, and that genetics-driven MWAS using locally trained scores can improve power and transferability. - All genetic scores from the work are publicly available through the OmicsPred portal (www.OmicsPred.org) to facilitate better-powered analyses in diverse AMR cohorts and address global inequities in omics research. - Data sources include MCPS, UK Biobank, and All of Us; ethical approvals and participant consent were obtained for all datasets used. - Specific model training details, complete variant lists, and additional analytic parameters were not exhaustively reported in the summary and are available in the study materials and supplementary resources referenced by the authors.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=9E8B9VO6BkWLuhHWyg25VHdw3SoCXy0s5bt204dLGao-1788843147.689169-1.2.1.1-4Bhv3BDTa2EBV8Qdm0oGrYBRbTo5MTQRhNbcCxZOAY4C.Ocw4uVvtQ_t1awzP5aE) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Enhanced power and transferability for genetics-driven metabolomic biomarker discovery in admixed American cohorts [ View ORCID Profile](http://orcid.org/0000-0001-7526-6151)Tin Orešković, [ View ORCID Profile](http://orcid.org/0000-0002-1368-0434)Danyao Jin, [ View ORCID Profile](http://orcid.org/0000-0002-7655-5905)Eirini Trichia, [ View ORCID Profile](http://orcid.org/0000-0003-2298-3768)Diego Aguilar-Ramirez, [ View ORCID Profile](http://orcid.org/0000-0002-7304-5045)Yu Xu, [ View ORCID Profile](http://orcid.org/0000-0001-8494-9595)Carles Foguet, [ View ORCID Profile](http://orcid.org/0009-0008-0689-710X)Tabitha Hubbard, [ View ORCID Profile](http://orcid.org/0000-0002-0351-4053)Michael Turner, [ View ORCID Profile](http://orcid.org/0000-0001-6262-2233)Alejandra Vergara-Lope, Luisa Fernández-Chirino, [ View ORCID Profile](http://orcid.org/0000-0002-9475-4502)Laurent Gil, [ View ORCID Profile](http://orcid.org/0000-0002-3861-6105)Michael R. Hill, [ View ORCID Profile](http://orcid.org/0000-0001-9390-3871)Jesús Alegre-Díaz, [ View ORCID Profile](http://orcid.org/0000-0001-6707-3317)Jaime Berumen, [ View ORCID Profile](http://orcid.org/0000-0002-4496-4771)Sarah Lewington, [ View ORCID Profile](http://orcid.org/0000-0001-7792-9422)Jonathan R. Emberson, [ View ORCID Profile](http://orcid.org/0000-0002-0704-9507)Pablo Kuri-Morales, [ View ORCID Profile](http://orcid.org/0000-0003-3814-2904)Roberto Tapia-Conyer, [ View ORCID Profile](http://orcid.org/0000-0002-7537-7035)Jason M. Torres, [ View ORCID Profile](http://orcid.org/0000-0001-9413-6520)Michael Inouye doi: https://doi.org/10.64898/2026.09.03.26362043 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Tin Orešković 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tin%2BOre%C5%A1kovi%C4%87%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ore%C5%A1kovi%C4%87%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATin%2BOre%25C5%25A1kovi%25C4%2587%2B) * [ORCID record for Tin Orešković](http://orcid.org/0000-0001-7526-6151 "Open in new tab") Danyao Jin 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Danyao%2BJin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jin%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADanyao%2BJin%2B) * [ORCID record for Danyao Jin](http://orcid.org/0000-0002-1368-0434 "Open in new tab") Eirini Trichia 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eirini%2BTrichia%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Trichia%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEirini%2BTrichia%2B) * [ORCID record for Eirini Trichia](http://orcid.org/0000-0002-7655-5905 "Open in new tab") Diego Aguilar-Ramirez 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Diego%2BAguilar-Ramirez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Aguilar-Ramirez%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADiego%2BAguilar-Ramirez%2B) * [ORCID record for Diego Aguilar-Ramirez](http://orcid.org/0000-0003-2298-3768 "Open in new tab") Yu Xu 2 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yu%2BXu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Xu%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYu%2BXu%2B) * [ORCID record for Yu Xu](http://orcid.org/0000-0002-7304-5045 "Open in new tab") Carles Foguet 2 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Carles%2BFoguet%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Foguet%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACarles%2BFoguet%2B) * [ORCID record for Carles Foguet](http://orcid.org/0000-0001-8494-9595 "Open in new tab") Tabitha Hubbard 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tabitha%2BHubbard%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hubbard%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATabitha%2BHubbard%2B) * [ORCID record for Tabitha Hubbard](http://orcid.org/0009-0008-0689-710X "Open in new tab") Michael Turner 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BTurner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Turner%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BTurner%2B) * [ORCID record for Michael Turner](http://orcid.org/0000-0002-0351-4053 "Open in new tab") Alejandra Vergara-Lope 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alejandra%2BVergara-Lope%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Vergara-Lope%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlejandra%2BVergara-Lope%2B) * [ORCID record for Alejandra Vergara-Lope](http://orcid.org/0000-0001-6262-2233 "Open in new tab") Luisa Fernández-Chirino 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Luisa%2BFern%C3%A1ndez-Chirino%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fern%C3%A1ndez-Chirino%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALuisa%2BFern%25C3%25A1ndez-Chirino%2B) Laurent Gil 2 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Laurent%2BGil%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Gil%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALaurent%2BGil%2B) * [ORCID record for Laurent Gil](http://orcid.org/0000-0002-9475-4502 "Open in new tab") Michael R. Hill 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BR.%2BHill%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hill%20MR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BR.%2BHill%2B) * [ORCID record for Michael R. Hill](http://orcid.org/0000-0002-3861-6105 "Open in new tab") Jesús Alegre-Díaz 3 Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jes%C3%BAs%2BAlegre-D%C3%ADaz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Alegre-D%C3%ADaz%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJes%25C3%25BAs%2BAlegre-D%25C3%25ADaz%2B) * [ORCID record for Jesús Alegre-Díaz](http://orcid.org/0000-0001-9390-3871 "Open in new tab") Jaime Berumen 3 Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jaime%2BBerumen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Berumen%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJaime%2BBerumen%2B) * [ORCID record for Jaime Berumen](http://orcid.org/0000-0001-6707-3317 "Open in new tab") Sarah Lewington 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sarah%2BLewington%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lewington%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASarah%2BLewington%2B) * [ORCID record for Sarah Lewington](http://orcid.org/0000-0002-4496-4771 "Open in new tab") Jonathan R. Emberson 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jonathan%2BR.%2BEmberson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Emberson%20JR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJonathan%2BR.%2BEmberson%2B) * [ORCID record for Jonathan R. Emberson](http://orcid.org/0000-0001-7792-9422 "Open in new tab") Pablo Kuri-Morales 3 Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pablo%2BKuri-Morales%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kuri-Morales%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APablo%2BKuri-Morales%2B) * [ORCID record for Pablo Kuri-Morales](http://orcid.org/0000-0002-0704-9507 "Open in new tab") Roberto Tapia-Conyer 3 Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Roberto%2BTapia-Conyer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tapia-Conyer%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARoberto%2BTapia-Conyer%2B) * [ORCID record for Roberto Tapia-Conyer](http://orcid.org/0000-0003-3814-2904 "Open in new tab") Jason M. Torres 1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jason%2BM.%2BTorres%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Torres%20JM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJason%2BM.%2BTorres%2B) * [ORCID record for Jason M. Torres](http://orcid.org/0000-0002-7537-7035 "Open in new tab") Michael Inouye 2 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BInouye%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Inouye%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BInouye%2B) * [ORCID record for Michael Inouye](http://orcid.org/0000-0001-9413-6520 "Open in new tab") * For correspondence: mi336@cam.ac.uk * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1294658/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1294658/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1294658/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1294658/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1294658/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.03.26362043v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1294658/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Despite metabolomics transforming our understanding of risk factors and aetiology of metabolic diseases, profiling is rarely performed for people of non-European ancestries, on whom much of metabolic disease burden falls. Metabolome-wide association studies (MWAS) can be performed using genetic scores to predict metabolomic traits, helping address these inequities; however, their performance in populations of admixed American (AMR) ancestries is unexplored. We evaluated 141 genetic scores, developed in an INTERVAL Study sample of European (EUR) genetic ancestries, in the Mexico City Prospective Study (MCPS; n=132,336), obtaining a median predictive R2 of 0.027. Training Bayesian ridge models within MCPS substantially improved performance, with a median R2 of 0.083 on a withheld 20% subset. MCPS-trained models also outperformed INTERVAL-trained models among UK Biobank participants of AMR ancestries (n=600; median R2: 0.070 vs. 0.046). Finally, among AMR participants of the All of Us cohort, using MCPS-trained (vs. INTERVAL-trained) models to predict metabolomic traits yielded five times as many significant associations (FDR-corrected P<0.05) across three cardiometabolic diseases: ischaemic heart disease, type 2 diabetes, and chronic kidney disease. The genetic scores are openly available at the OmicsPred portal (www.OmicsPred.org), enabling better-powered analyses in diverse AMR cohorts and helping reduce global inequities in omics research. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Our work complies with the relevant ethical regulations: all studies used in this work were approved by the relevant board or committee. The Mexico City Prospective Study was approved by the Mexican Ministry of Health, the Mexican National Council for Science and Technology (0595 P-M), the Central Oxford Research Ethics Committee (C99.260), and the Medical Ethics Committee of the National Autonomous University of Mexico (FMED/CEI/MHU/2020); all MCPS participants provided written informed consent. The UK Biobank has approval from the North West Multi-centre Research Ethics Committee (reference 21/NW/0157), which is renewed every five years; all UKB participants provided infor
## Related Clinical Research

- [KERENDIA FDA Approval for CKD in Type 1 Diabetes and Arrowhead’s Plozasiran SHASTA-3/4 Phase 3 Res](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-september-18-2026.md)
- [Central thyroid hormone resistance and CKD risk in type 2 diabetes: cross-sectional analysis](https://medichelpline.com/clinical-feed/pubmed-42755292.md) (DOI: 10.1080/0886022X.2026.2731649)
- [Adherence to Medications, Lifestyle Advice, and Self‑Monitoring for Type 2 Diabetes and Hypertensi](https://medichelpline.com/clinical-feed/plos-medicine-0-adherence-to-medications-lifestyle-advice-and-self-monitoring-for-type-2.md)
- [Quality of Type 2 Diabetes Care in Malaysian Primary Care: ABC (HbA1c, BP, LDL-C) Scoping Review](https://medichelpline.com/clinical-feed/plos-one-3-the-quality-of-care-for-type-2-diabetes-mellitus-management-in-malaysian.md)
- [Single-cell scTWAS identifies immune cell–specific genes linked to gestational diabetes](https://medichelpline.com/clinical-feed/plos-one-0-leveraging-expression-quantitative-trait-loci-information-in-single-cell.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.